236 Users Online
Peripherally Inserted Central Catheters Market Segmented Power Injected, Conventional Peripherally Inserted Central Catheter in Single Lumen, Double Lumen, Multi Lumen Design
Peripherally inserted central catheters constitute a single subtype of catheters that are specifically used for IV administration especially for continuous therapy ranging from more than a week to less than five weeks. The indications for peripherally inserted central catheters include chemotherapy drugs, parenteral nutrition, blood sample withdrawal, and many more.
Depending upon the duration of therapy and type of the disease indication the choice of peripherally inserted central catheters can be made for insertion. In this report we have categorized peripherally inserted central catheters only in two types namely power injected peripherally inserted central catheters and conventional peripherally inserted central catheters.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The global peripherally inserted central catheters market is projected to register a CAGR of 5.8% during the forecast period (2016 – 2024) in terms of value. Global peripherally inserted central catheters market value is expected to increase to US$ 1058.6 Mn by the end of 2024.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionGrowth of the global peripherally inserted central catheters market is mainly driven by increasing healthcare expenditure, robust reimbursement policies, increasing preference for peripherally inserted central catheters by healthcare physicians, and increasing number of diseases requiring the application of peripherally inserted central catheters. However, factors such as increasing usage of midline catheters, lack of specialized professionals for catheterization, and high risk of bloodstream infections and deep vein thrombosis are likely to hamper the growth of the global peripherally inserted central catheters market over the forecast period.
Technological advancements in peripherally inserted central catheters and recent demand based innovations such as the introduction of anti-microbial peripherally inserted central catheters and anti-thrombogenic peripherally inserted central catheters will define the future landscape of the global peripherally inserted central catheters market.
The global peripherally inserted central catheters market is segmented as under:
By Product
By Design
By End User
The Power Injected Peripherally Inserted Central Catheters product type segment is estimated to account for 82.3% revenue share of the global peripherally inserted central catheters market by 2016 end. This segment is anticipated to register a CAGR of 6.0% during the forecast period. The Multiple Lumen design segment dominated the global peripherally inserted central catheters market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period, registering a CAGR of 6.7% in terms of value. The Hospitals end user segment is estimated to account for 69.1% revenue share of the global peripherally inserted central catheters market by 2016 end and register a CAGR of 6.0% during the forecast period.
Sales Team
Client Partner
The global peripherally inserted central catheters market is segmented into the five key regions of North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America peripherally inserted central catheters market is estimated to account for 81.5% revenue share of the global peripherally inserted central catheters market by 2016 end. This market is expected to register a CAGR of 4.2% over the forecast period. APAC and Europe are estimated to be the fastest growing markets in terms of CAGR.
AngioDynamics Inc., C. R. Bard Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic plc, Vygon S.A, Cook Medical Inc., Argon Medical Devices Inc., Medical Component Inc., and Theragenics Corporation are some of the top companies operating in the global peripherally inserted central catheters market. Leading players operating in the global peripherally inserted central catheters market are collaborating with other key healthcare solutions and services providers in order to advance their operational efficiencies and provide improved patient care.
The global peripherally inserted central catheters market is dominated by few key players such as Teleflex Incorporated, AngioDynamics Inc., C.R. Bard Inc., Vygon S.A, and Cook Medical Inc. and together, these companies constitute around 80%-85% of the overall market share.
